This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Bernd Rosenstock: Innovator in Antiviral Research
Introduction
Bernd Rosenstock is a notable inventor based in Neu-Isenburg, Germany. He has made significant contributions to the field of antiviral research, particularly through his innovative work on substituted quinoline derivatives. His dedication to advancing medical science is reflected in his patent portfolio.
Latest Patents
Rosenstock holds a patent for "Substituted quinoline derivatives with antiviral action." This invention showcases his commitment to developing new therapeutic agents that can combat viral infections. He has 1 patent to his name, highlighting his innovative contributions to the field.
Career Highlights
Throughout his career, Bernd Rosenstock has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on research and development, contributing to advancements in antiviral therapies.
Collaborations
Rosenstock has collaborated with esteemed colleagues, including Reinhard Kirsch and Jorg-Peter Kleim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Bernd Rosenstock is a dedicated inventor whose work in antiviral research has the potential to make a significant impact on public health. His innovative spirit and collaboration with other experts in the field continue to drive advancements in medical science.